"Cell Engineering" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods and techniques used to modify or select cells and develop conditions for growing cells for biosynthetic production of molecules (METABOLIC ENGINEERING), for generation of tissue structures and organs in vitro (TISSUE ENGINEERING), or for other BIOENGINEERING research objectives.
Descriptor ID |
D060846
|
MeSH Number(s) |
E05.481.500.311 J01.293.069.249
|
Concept/Terms |
Cell Engineering- Cell Engineering
- Engineering, Cell
- Cellular Engineering
- Engineering, Cellular
|
Below are MeSH descriptors whose meaning is more general than "Cell Engineering".
Below are MeSH descriptors whose meaning is more specific than "Cell Engineering".
This graph shows the total number of publications written about "Cell Engineering" by people in this website by year, and whether "Cell Engineering" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2012 | 3 | 0 | 3 |
2013 | 3 | 1 | 4 |
2014 | 6 | 2 | 8 |
2015 | 6 | 4 | 10 |
2016 | 4 | 2 | 6 |
2017 | 2 | 5 | 7 |
2018 | 6 | 2 | 8 |
2019 | 4 | 4 | 8 |
2020 | 6 | 3 | 9 |
2021 | 4 | 6 | 10 |
2022 | 1 | 4 | 5 |
2023 | 0 | 2 | 2 |
2024 | 3 | 1 | 4 |
Below are the most recent publications written about "Cell Engineering" by people in Profiles.
-
Programming tissue-sensing T cells that deliver therapies to the brain. Science. 2024 Dec 06; 386(6726):eadl4237.
-
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs. Science. 2024 Dec 06; 386(6726):eadl4793.
-
Robust genome and cell engineering via in vitro and in situ circularized RNAs. Nat Biomed Eng. 2025 Jan; 9(1):109-126.
-
In vivo human T cell engineering with enveloped delivery vehicles. Nat Biotechnol. 2024 Nov; 42(11):1684-1692.
-
Novel extragenic genomic safe harbors for precise therapeutic T-cell engineering. Blood. 2023 06 01; 141(22):2698-2712.
-
Advancing cell-based cancer immunotherapy through stem cell engineering. Cell Stem Cell. 2023 05 04; 30(5):592-610.
-
Synthetic cytokine circuits that drive T cells into immune-excluded tumors. Science. 2022 12 16; 378(6625):eaba1624.
-
Programming multicellular assembly with synthetic cell adhesion molecules. Nature. 2023 02; 614(7946):144-152.
-
The emerging era of cell engineering: Harnessing the modularity of cells to program complex biological function. Science. 2022 11 25; 378(6622):848-852.
-
Rethinking cancer targeting strategies in the era of smart cell therapeutics. Nat Rev Cancer. 2022 12; 22(12):693-702.